Respond.io Revenue and Competitors
Estimated Revenue & Valuation
- Respond.io's estimated annual revenue is currently $22.5M per year.
- Respond.io's estimated revenue per employee is $159,500
Employee Data
- Respond.io has 141 Employees.
- Respond.io grew their employee count by 66% last year.
Respond.io Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $57.6M | 318 | 24% | N/A | N/A |
#2 | $44.6M | 286 | 23% | $25.4M | N/A |
#3 | $5.1M | 44 | -6% | N/A | N/A |
#4 | $35.1M | 225 | -3% | $46.9M | N/A |
#5 | $14.5M | 100 | 5% | N/A | N/A |
#6 | $1.3M | 15 | -6% | N/A | N/A |
#7 | $1.5M | 17 | 0% | N/A | N/A |
#8 | $2.9M | 29 | -12% | N/A | N/A |
#9 | $125.2M | 691 | 6% | N/A | N/A |
#10 | $95.9M | 529 | -1% | N/A | N/A |
What Is Respond.io?
Respond.io is a business messaging platform that connects customers from any channel to every team. As consumers grow to demand personal communication on a wide variety of channels, businesses are looking to their software vendors and partners to innovate and deliver these customer experiences. We're here to make customer communication simple, engaging & fruitful.
keywords:N/AN/A
Total Funding
141
Number of Employees
$22.5M
Revenue (est)
66%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Respond.io News
Australian technology firm Attentis has developed an intelligent system of sensors to provide local officials and emergency response teams...
Which patients are more likely to achieve a CR [complete response] vs a PR with lenvatinib-pembrolizumab? Arnab Basu, MD: This is an ongoing...
However, being different from the popular belief, some other factors such as IOs' policy fields (whether an IO deals with health, economics,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $22.5M | 141 | -5% | N/A |
#2 | $51.2M | 141 | 8% | N/A |
#3 | $41.9M | 141 | 3% | N/A |
#4 | $15M | 141 | 9% | N/A |
#5 | $41.9M | 141 | 12% | N/A |